Alx Oncology Holdings (ALXO) Long-Term Investments (2022 - 2026)

Alx Oncology Holdings has reported Long-Term Investments for 5 years, with the latest figure at $28.8 million in Q1 2026.

• Quarterly Long-Term Investments rose 214.19% year-over-year to $28.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.8 million (up 214.19% YoY) and the FY2025 annual result came in at $3.5 million, down 0.85% from the prior year.
• Long-Term Investments improved to $28.8 million in Q1 2026 per ALXO's latest filing, from $3.5 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $35.4 million in Q4 2023 and troughed at $3.5 million in Q4 2025.
• A 5-year average of $15.8 million and a median of $11.6 million in 2023 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2024 and 2026: Long-Term Investments plunged 90.05% in 2024, then soared 214.19% in 2026.
• Over 5 years, Long-Term Investments stood at $16.7 million in 2022, then surged by 112.05% to $35.4 million in 2023, then slumped by 90.05% to $3.5 million in 2024, then dropped by 0.85% to $3.5 million in 2025, then jumped by 723.78% to $28.8 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $28.8 million, $3.5 million, and $5.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.